Transcript profiling technology enables quantitative measurement of the tra
nscriptional activity of potentially thousands of genes in biological sampl
es. The application of such technology to toxicology, toxicogenomics, promi
ses substantial dividends in mechanistic toxicity research and also, possib
ly, the ability to predict adverse toxicity for novel or untested compounds
. Our laboratory has developed a custom approach to this technology, design
ing cDNA microarray platforms specifically for gene expression events of re
levance to a large number of toxicological endpoints. Such arrays allow com
prehensive coverage of genes associated with entire pathways (such as oxida
tive stress, signal transduction, stress response, epithelial biology) and
enable simultaneous measurement of more than ten thousand gene expression e
vents. (C) 2001 Published by Elsevier Science Ireland Ltd.